直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

Federal Circuit IP Blog

$85 million Verdict Affirmed: Federal Circuit Shuts Down Ingevity’s Challenge to Antitrust Verdict

February 27, 2026

Authored and Edited by Ryan V. McDonnell; *Jessica M. Ott

In Ingevity Corp. v. BASF Corp., No. 2024-1577 (Fed. Cir. Feb. 11, 2026), the Federal Circuit affirmed an $85 million trebled jury verdict against Ingevity for unlawful tying under the Sherman Act. Ingevity initially sued BASF for infringing U.S. Patent No. RE38,844 (“the ’844 Patent”) but the district court determined that the patent was invalid on summary judgment leaving only BASF’s counterclaims for antitrust and tortious interference for a jury trial.  

The jury found that Ingevity illegally tied licenses of the ‘844 patent to purchase agreements for Ingevity’s unpatented air filter, a staple good with significant non-infringing use. After trial, Ingevity moved for judgment as a matter of law or a new trial, arguing that (1) patent owners have a statutory right to control non-staple goods capable only of infringing use in a patented invention, even if it would suppress competition in the market for an unpatented commodity per the patent misuse defense under 35 U.S.C. § 271(d), (2) Noerr-Pennington immunity applied, and (3) the jury failed to disaggregate damages between lawful and unlawful conduct and that BASF’s damages model was speculative. The district court denied Ingevity’s motions. Ingevity appealed.

The Federal Circuit affirmed. First, the Court determined that § 271(d) did not apply because the jury heard sufficient evidence demonstrating that the Ingevity’s filter was a staple good with substantial non-infringing use. Second, the Court determined that Ingevity forfeited its argument under Noerr-Pennington because it materially changed its argument on appeal by abandoning its prior argument that only patent enforcement actions—not commercial tying—were immune from antitrust liability. Third, the Court determined that BASF had demonstrated that Ingevity’s illegal conduct was a material cause of BASF’s injury, and that the jury permissibly credited BASF’s damages expert’s testimony on the impossibility of disaggregation.  

Related Practices

Appeals, Issues, and Legal Strategy

Federal Circuit and Supreme Court Appeals

Diligence, Licensing, and Opinions

Licensing, Pooling, and Other Transactions

Global IP Enforcement, Litigation, and Trials

Antitrust and Misuse

Related Industries

Chemicals, Industrials, and Materials

Related Offices

Reston, VA

Washington, DC

Contacts

Ryan V. McDonnell
Associate
Washington, DC
+1 202 408 4167
Email

*Jessica M. Ott is a Law Clerk at Finnegan

Copyright © 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 

DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information

Related Insights

Conference

ChIPs Global Summit 2026

October 21-23, 2026

Los Angeles

Conference

IAM Live: SEP Summit Global 2026

September 9-10, 2026

London

Lecture

Resolving Patent Suits Without Settlement Payments

September 3, 2026

Virtual

Conference

Singapore IP Week 2026

August 26-27, 2026

Conference

Georgia Life Sciences Summit 2026

August 25-26, 2026

Sandy Springs

Conference

Finnegan IP Summit 2026: Celebrating an Inclusive Talent Pipeline

August 11-13, 2026

Washington, DC

Conference

13th Annual Summit for Women Leaders in Life Sciences Law

July 29-30, 2026

Boston

Webinar

U.S. Patent Case Law Update 2026

July 23, 2026

Webinar

Webinar

Successful Strategies to Win Alice Motions and Fee Awards in Patent Cases Against Non-Practicing Entities

July 22, 2026

Webinar

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP